| | Infection | RTX
| No RTX
| value |
| | Viral, % () | 44 (24) | 27 (103) | 0.012 | | CMV infection, % () | 20 (11) | 19 (72) | 0.81 | | BK viremia, % () | 27 (15) | 13 (51) | 0.011 | | BK nephropathy, % () | 15 (8) | 4 (14) | 0.003 | | Other viral, % () | 15 (8) | 2 (6) | <0.001 | | Ebstein Barr virus, | 1 | 0 | | | Human papilloma virus, | 0 | 1 | | | Influenza A, | 0 | 2 | | | Influenza H1N1, | 1 | 2 | | | JCV-associated PML, | 1 | 0 | | | Respiratory syncytial virus, | 1 | 0 | | | Varicella zoster, | 4 | 1 | | | Number of viral infections/patient | 0.6 | 0.3 | 0.005 | | Fungal, % () | 11 (6) | 3 (10) | 0.009 | | Aspergillosis, pulmonary, | 0 | 4 | | | Candida infections, | 4 | 3 | | | Cryptococcal meningoencephalitis, | 0 | 3 | | | Nonaspergillus mould, pulmonary, | 1 | 0 | | | Mucormycosis, pulmonary, | 0 | 1 | | | Tinea corpis, disseminated, | 1 | 0 | | | Number of fungal infections/patient | 0.11 | 0.03 | 0.006 |
|
|
